Particle Size or Particle Number? Why Small Dense LDL Is a Signpost, Not the Mechanism

Evidence Note EN-03 of The VAT Trap Evidence Notes. For three decades, small dense LDL has been described as the dangerous kind: nimble enough to enter the arterial wall, sticky enough to be retained, prone to oxidation once trapped. This note examines whether particle size is the mechanism of harm, or a marker of something else. The claim defended is narrow and precise: at a given number of LDL particles, particle size does not independently predict cardiovascular risk. Small dense LDL is associated with events because it travels with a higher particle count and with the metabolic dysfunction that generated it. Supporting evidence is drawn from discordance analyses in MESA and the Framingham Offspring Study, from the interplay of particle number and size across the UK Biobank, Women's Health Study and Framingham Heart Study, and from familial hypercholesterolaemia — the case that breaks the size hypothesis, since patients with the most lethal inherited lipid disorder carry predominantly large particles. Two figures illustrate the argument: the same cholesterol distributed among different numbers of containers, and the visceral versus subcutaneous compartment distinction that links central adiposity to hepatic particle production. Following the series architecture, section §E3 states what the evidence does not show: the size effect is unconfirmed rather than proven absent; the added value of particle number over a complete risk model was abolished in EPIC-Norfolk after adjustment for triglycerides and HDL cholesterol; no randomised trial has compared management guided by apoB or LDL-P with management guided by LDL cholesterol using clinical endpoints; and nothing here establishes that reducing visceral fat reduces cardiovascular events. Written for clinicians and informed readers. Educational only — not a diagnostic instrument and not individual medical advice. Financial interests declared in the note.